NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

There is a tendency, sometimes, to slip into the notion that delay in moving forward is bottlenecked by the CI Pharma companies’ stranglehold on the biotech economy. Particularly the PD-1 group. Perhaps that was/is partly true, but obviously coming to an end.

On the other hand, there was Covid, resulting in well known supply chain shortages for companies around the world, and the UK morphing out of its Brexit cocoon. These obviously slowed progress.

Right now, it seems like Advent’s, MHRA’s and the UK’s chance to shine, and, along with alternative interim reimbursement
pathways in the UK, step up for their citizens, whom are not fairing well in GBM treatment under the old system.

Advent is incentivized to use its brief but forthcoming pre-Eden commercial era well, in order to help fellow citizens, help prepare for eventual Eden commercial engineering runs, and ultimately transition much of their production workforce from manual UK production, into automated UK production for UK, Europe and beyond.

It’s hard to imagine more humanitarian and economic motivation for Advent, Flaskworks/NWBO and the UK to get on it and start easing the suffering of fellow citizens, and eventually, patients around the globe similarly situated.